Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer.


The significance of phosphorylated mTOR (p-mTOR) expression is unknown in triple-negative breast carcinoma (TNBC). The aims of the present study were to assess the expression of p-mTOR in early TNBC and to evaluate possible correlations between androgen receptor (AR) expression, clinicopathological parameters and disease outcome. Between January 2009 and… (More)
DOI: 10.3892/or.2016.4903

7 Figures and Tables


  • Presentations referencing similar topics